Newsletter Subject

UK aims to give 1st COVID-19 shot to all adults by September

From

pte.la

Email Address

editor@pte.la

Sent On

Sun, Jan 17, 2021 05:30 PM

Email Preheader Text

EMAIL}/redirect SUNDAY, JANUARY 17, 2021 | DANICA KIRKA, ASSOCIATED PRESS LONDON — The U.K. gov

[Image]( EMAIL}/redirect SUNDAY, JANUARY 17, 2021 | DANICA KIRKA, ASSOCIATED PRESS LONDON (AP) — The U.K. government plans to offer a first dose of COVID-19 vaccine to every adult by September as the nation’s health care system battles the worst crisis in its 72-year-history. Foreign Secretary Dominic Raab said Sunday that the government will soon begin a trial of round the clock injections at some locations as it continues to add more vaccination sites to increase the pace of delivery. The National Health Service opened a mass vaccination center on Saturday at the historic Salisbury Cathedral, where injections were accompanied by organ music. “Our target is by September to have offered all the adult population a first dose,’’ he told Sky News. “If we can do it faster than that, great, but that’s the road map.” Britain has more than 51 million adults in its population of 67.5 million people. The ambitious vaccination program comes amid crushing pressures on the National Health Service. Already beleaguered hospitals are admitting another COVID-19 patient every 30 seconds, putting the service in its most precarious situation ever, said Simon Stevens, chief executive of NHS England. “The facts are very clear and I’m not going to sugarcoat them, hospitals are under extreme pressure and staff are under extreme pressure,’’ he told the BBC. “Since Christmas Day we’ve seen another 15,000 increase in the in-patients in hospitals across England. That’s the equivalent of filling 30 hospitals full of coronavirus patients.” Britain’s health care system is staggering as doctors and nurses battle a more contagious variant of the coronavirus coupled with cold, wet winter weather that drives people inside, where infections spread more easily. The surge in infections has pushed the number of people hospitalized with COVID-19 to a record 37,475, more than 73% higher than during the first peak of the pandemic in April. Britain has reported 88,747 coronavirus-related deaths, more than any other country in Europe and the fifth-highest number worldwide. EMAIL}/redirect EMAIL}/redirect Prime Minister Boris Johnson on Jan. 2 ordered England into its third national lockdown in an effort to slow the spread of the virus and protect the NHS, which Stevens said now has some 50,000 employees off work due to COVID-19 infections and exposure quarantines. The government says it won’t review the lockdown measures until mid-February, by which time it plans to offer at least one dose of vaccine to everyone over 70, as well as to frontline health care workers and others who are especially vulnerable to COVID-19. Once that goal has been reached, the U.K. will offer the vaccine to everyone over 50 before finally moving on to everyone over 18. Unlike other nations, Britain has chosen to stretch out the time between vaccine doses from 21 days to up to 12 weeks — a decision that means more people will get at least one dose more quickly. EMAIL}/redirect EMAIL}/redirect Britain has approved three vaccines — ones by Pfizer-BioNTech, Oxford-AstraZeneca and Moderna. The first two are already being used, while the Moderna doses are not expected until spring. Meanwhile, vaccination centers are being opened in England at some of the country's great cathedrals. Salisbury Cathedral, which also houses a copy of the Magna Carta, opened its great nave to the public. Others will follow as the rollout continues. Organ music played as the jabs were delivered at Salisbury. Requests were taken. “I doubt that anyone is having a jab in surroundings that are more beautiful than this, so I hope it will ease people as they come into the building,” said the Very Rev. Nicholas Papadopulos, Dean of Salisbury. EMAIL}/redirect EMAIL}/redirect © 2020 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as are commendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit . PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. PTE.la is owned and operated by PTE LLC. PTE LLC has not been compensated for this specific email, we do have advertisements in this email that we get paid if you click one of the ads (we have not investigated any of the advertisements). Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. PTE Team 9 Downing street Newark NJ 07105 USA [Unsubscribe]( [Change subscriber options](

EDM Keywords (203)

written writers well website warranty virus viewer verifying value vaccine users user used us urged undertake uncertainties trial told time target taken table surroundings surge sugarcoat stretch statement staggering staff spread solicitation solely slow size shares service september selling sell seek security securities saturday sale round risks risk reviewing review responsibility respect representation reliable releases release registered recommendation reached pushed purport purchasing purchase provided provide protect prospects products possible position population plans people patients pandemic pace owner owned otherwise others opinion operation operated opened offered offer number notify nhs nation moderna means meaning may market making make made lost lose long locations limited keep jabs jab investors investment investing investigated investigate interest intended injections information infections indicative increase implied hospitals hope held guarantees guaranteed growth great government going goal get fund follow filings faster facts expression expected everyone europe equivalent england engaged employees email either effort easily doubt doctors discussed disclosures described delivery delivered decrease decisions decision country copy continues content consulting consult construed considered conflict completeness compensated company commendation come clear chosen carries buy business believe beautiful based aware available attuned appropriateness appropriate anyone analysis already afford advised advice advertising advertisements adults ads addition add accurate accuracy accordance accompanied ability 70 50 1995

Marketing emails from pte.la

View More
Sent On

31/03/2023

Sent On

13/03/2023

Sent On

08/03/2023

Sent On

01/02/2023

Sent On

30/01/2023

Sent On

20/01/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.